Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel 18F-labeled tryptophan analogue as a PET imaging probe for Shh medulloblastoma

March 11, 2020

AbbVie begins first-in-human study of ABBV-184 in previously treated AML and NSCLC

March 11, 2020

Clavius Pharmaceuticals synthesizes new TGFBR1 inhibitors

March 10, 2020

U.S. researchers present CDK8 or CDK19 inhibitors

March 10, 2020

TRPV4 found expressed in cartilaginous tumors and may be a potential therapeutic target

March 10, 2020

Ascentage cleared to begin new trials of APG-2575 in U.S. and China

March 9, 2020

Netherlands Cancer Institute plans phase I/Ib study of RMC-4630 with ERK inhibitor

March 9, 2020

ALRN-6924 upregulates P21 expression in AML/MDS patients

March 9, 2020

Nanjing TransThera Biosciences identifies TAM family kinases inhibitors

March 9, 2020

Shanghai Allist Pharmaceutical discloses EGFR mutant inhibitors

March 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...